FDA Inspection 802505 — Patient Advocacy Council Inc

Patient Advocacy Council Inc — FEI 3003075254

The FDA completed an inspection of Patient Advocacy Council Inc on Oct 4, 2012 in Mobile, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 4, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mobile, AL (United States)

Additional Details

IRB